Stem-cell biology and cancer therapy: The more things change...

Journal of Clinical Oncology

Volumn 26, Issue 6, 2008, Pages 821-822

  Hellman, Samuel ^a   Botnick, Leslie ^b   Mauch, Peter ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b Valley Radiotherapy Medical Group and Vantage Oncology   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUOROURACIL; METHOTREXATE; NITROSOUREA; VINBLASTINE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; BONE MARROW TOXICITY; CANCER THERAPY; CELL DIVISION; CELL PROLIFERATION; CYTOTOXICITY; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; HUMAN; IONIZING RADIATION; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL; RADIATION EXPOSURE; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; ARTICLE; CANCER STEM CELL; DRUG EFFECT; HEMATOPOIETIC STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASTIC STEM CELLS;

EID: 39749194568     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.1416     Document Type: Note

References (0)